Brinkmann R, Roider J, Birngruber R
University of Lübeck, Institute of Biomedical Optics, Medical Laser Center Lübeck, Germany.
Bull Soc Belge Ophtalmol. 2006(302):51-69.
Selective retina therapy (SRT) is a new laser procedure for retinal diseases that are thought to be associated with a degradation of the retinal pigment epithelium (RPE). The aim of the irradiation is to selectively damage the RPE without affecting the neural retina, the photoreceptors and the choroid. Goal of the treatment is to stimulate RPE cell migration and proliferation into the irradiated areas in order to improve the metabolism at the diseased retinal sites. In a pilot study more than 150 patients with soft drusen, retinopathia centralis serosa (RCS) and macular edema were treated. The first 3-center international trial targets diabetic macular edema and branch vein occlusion. In this review, selective RPE effects are motivated and two modalities to achieve selective RPE effects will be introduced: a pulsed and a continuous wave scanning mode. The mechanism behind selective RPE-effects will be discussed reviewing in vitro results and temperature calculations. So far clinical SRT is performed by applying trains of 30 laser pulses from a Nd:YLF-Laser (527 nm, 1.7 micros, 100 Hz) to the diseased fundus areas. In the range of 450-800 mJ/cm(2) per pulse, RPE-defects in patients were proved angiographically by fluorescein or ICG-leakage. The selectivity with respect to surrounding highly sensitive tissue and the safety range of the treatment will be reviewed. With the laser parameters used neither bleeding nor scotoma, proved by microperimetry, were observed thus demonstrating no adverse effects to the choroid and the photoreceptors, respectively. During and after irradiation, it shows that the irradiated locations are ophthalmoscopically invisible, since the effects are very limited and confined to the RPE, thus a dosimetry control is demanded. We report on a non-invasive opto-acoustic on-line technique to monitor successful RPE-irradiation and compare the data to those achieved with standard angiography one-hour post treatment.
选择性视网膜治疗(SRT)是一种针对被认为与视网膜色素上皮(RPE)退化相关的视网膜疾病的新型激光手术。照射的目的是选择性地损伤RPE,而不影响神经视网膜、光感受器和脉络膜。治疗的目标是刺激RPE细胞迁移并增殖到照射区域,以改善患病视网膜部位的新陈代谢。在一项初步研究中,对150多名患有软性玻璃疣、中心性浆液性视网膜病变(RCS)和黄斑水肿的患者进行了治疗。首个三中心国际试验针对糖尿病性黄斑水肿和分支静脉阻塞。在本综述中,阐述了选择性RPE效应的原理,并将介绍实现选择性RPE效应的两种模式:脉冲扫描模式和连续波扫描模式。将结合体外研究结果和温度计算来讨论选择性RPE效应背后的机制。到目前为止,临床SRT是通过从Nd:YLF激光(527 nm,1.7微秒,100 Hz)向患病眼底区域发射30个激光脉冲序列来进行的。在每个脉冲450 - 800 mJ/cm²的范围内,通过荧光素或吲哚菁绿(ICG)渗漏的血管造影术证实了患者存在RPE缺陷。将对相对于周围高度敏感组织的选择性以及治疗的安全范围进行综述。使用所采用的激光参数,未观察到微视野检查证实的出血或暗点,从而分别证明对脉络膜和光感受器没有不良影响。在照射期间和照射后,由于效应非常有限且局限于RPE,所以在检眼镜下照射部位不可见,因此需要剂量控制。我们报告一种非侵入性光声在线技术,用于监测RPE照射是否成功,并将数据与治疗后一小时通过标准血管造影术获得的数据进行比较。